Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016, Article ID 1648047, 7 pages
http://dx.doi.org/10.1155/2016/1648047
Clinical Study

High Dose Ilaprazole/Amoxicillin as First-Line Regimen for Helicobacter pylori Infection in Korea

1Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang 10326, Republic of Korea
2Department of Biostatistics, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang 10326, Republic of Korea
3Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, TX, USA

Received 24 March 2016; Revised 22 May 2016; Accepted 26 May 2016

Academic Editor: Tatsuya Toyokawa

Copyright © 2016 WonGun Kwack et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • Anthony O'Connor, Dominique Lamarque, Javier P. Gisbert, and Colm O'Morain, “ Treatment of Helicobacter pylori infection 2017 ,” Helicobacter, vol. 22, pp. e12410, 2017. View at Publisher · View at Google Scholar
  • Chih-Chieh Huang, Kuo-Wang Tsai, Tzung-Jiun Tsai, and Ping-I Hsu, “Update on the first-line treatment for Helicobacter pylori infection - a continuing challenge from an old enemy,” Biomarker Research, vol. 5, no. 1, 2017. View at Publisher · View at Google Scholar
  • Yi Hu, Yin Zhu, and Nong-Hua Lu, “Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance,” Frontiers in Cellular and Infection Microbiology, vol. 7, 2017. View at Publisher · View at Google Scholar
  • Yong Xie, Xiaolin Pan, Yan Li, Huahong Wang, Yiqi Du, Jianming Xu, Jiangbin Wang, Zhirong Zeng, Ye Chen, Guoxin Zhang, Kaichun Wu, Dongsheng Liu, and Nonghua Lv, “New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese prospective, randomized, multicentre trial,” Journal of Antimicrobial Chemotherapy, 2018. View at Publisher · View at Google Scholar
  • Seong Ju Lee, Yun Jeong Lim, Seok Bo Hong, Ji Hyung Nam, Dong Kee Jang, Hyoun Woo Kang, Jae Hak Kim, Jun Kyu Lee, Moon-Su Koh, and Jin Ho Lee, “ Standard First-line Triple Therapy for Helicobacter pylori Infection: A Comparison of Eradication Rates Based on Timing of Administration of Proton Pump Inhibitors ,” The Korean Journal of Helicobacter and Upper Gastrointestinal Research, vol. 18, no. 2, pp. 115, 2018. View at Publisher · View at Google Scholar
  • Lou Yu, Laisheng Luo, Xiaohua Long, Xiao Liang, Yingjie Ji, David Y. Graham, and Hong Lu, “ High‐dose PPI‐amoxicillin dual therapy with or without bismuth for first‐line Helicobacter pylori therapy: A randomized trial ,” Helicobacter, pp. e12596, 2019. View at Publisher · View at Google Scholar
  • Hiroshi Matsumoto, Akiko Shiotani, and David Y. Graham, “Current and Future Treatment of Helicobacter pylori Infections,” 2019. View at Publisher · View at Google Scholar
  • Jing Yang, Yi Zhang, Ling Fan, Yang-Jie Zhu, Ting-Yi Wang, Xing-Wei Wang, Dong-Feng Chen, and Chun-Hui Lan, “Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori,” The American Journal of Gastroenterology, vol. 114, no. 3, pp. 437–445, 2019. View at Publisher · View at Google Scholar
  • Wei-Chen Tai, Chih-Ming Liang, Chung-Mou Kuo, Pao-Yuan Huang, Cheng-Kun Wu, Shih-Cheng Yang, Yuan-Hung Kuo, Ming-Tsung Lin, Chen-Hsiang Lee, Chien-Ning Hsu, Keng-Liang Wu, Tsung-Hui Hu, and Seng-Kee Chuah, “ A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti- Helicobacter pylori treatment in Taiwan: a prospective randomized trial ,” Journal of Antimicrobial Chemotherapy, 2019. View at Publisher · View at Google Scholar